Skip to main content

Table 2 Biochemical variables in patients according to glucometabolic status classified by an OGTT in-hospital and at three-month

From: Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study

 

NGR (in-hospital) (n = 119)

AGR (in-hospital) (n = 105)

P

NGR (at three-month) (n = 151)

AGR (at three-month) (n = 50)

P

HbA1c (%)

5.5 (5.3, 5.7)

5.6 (5.4, 5.8)

<0.01

5.5 (5.4, 5.7)

5.8 (5.5, 6.2)

<0.0001

Insulin (pmol/L)

66 (46, 87)

73 (53,108)

0.03

63 (39, 82)

75 (47, 112)

0.02

C-peptid (pmol/L)

788 (638, 1026)

1026 (728, 1241)

<0.001

834 (636, 1077)

893 (728, 1129)

0.11

Proinsulin (pmol/L)

6.8 (4.7, 10.4)

8.6 (5.8, 13.9)

0.02

5.4 (4.3, 8.5)

7.5 (5.4, 10.3)

0.01

HOMA-IR (mU mmol-1 L-1)

2.45 (1.63, 3.36)

3.00 (2.11, 4.92)

<0.001

2.20 (1.45, 3.23)

3.15 (2.08, 4.99)

<0.01

Proinsulin: insulin ratio

0.12 (0.08, 0.19)

0.13 (0.08, 0.18)

0.87

0.10 (0.07, 0.15)

0.12 (0.07, 0.18)

0.41

  1. Data are presented as median values (25, 75 percentiles)
  2. AGR: abnormal glucose regulation, NGR: normal glucose regulation.